1 / 33

Pharmacology

Pharmacology . Dentalelle tutoring www.dentalelle.com. CHAPTER THREE. ADVERSE REACTIONS. OBJECTIVES. Define and explain the adverse reactions to drugs.

sibyl
Download Presentation

Pharmacology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Pharmacology Dentalelle tutoring www.dentalelle.com

  2. CHAPTER THREE ADVERSE REACTIONS

  3. OBJECTIVES • Define and explain the adverse reactions to drugs. • Explain the different types of adverse reactions that can occur such as toxicity, allergic reactions, side effects and idiosyncratic responses. • Describe common signs and symptoms of an adverse drug reaction. • Summarize dental hygiene considerations that apply to drug action, handling and adverse reactions.

  4. Adverse Reactions • Drugs cause good (therapeutic effect) and bad effects (adverse effect) and this is because drugs act on many tissues at the same time. • Adverse effects can happen at usual therapeutic doses.

  5. CLASSIFICATIONS OF ADVERSE REACTION • TOXIC REACTION: • The amount of the desired effect is excessive; dose related • Predictable • Dose-related • Acts on target organs • Extension of the drug’s pharmacologic effects • E.G include: hypoglycemia with an oral hypoglycemic agent or insulin * Drug allergies are not examples of dose-related response –WHY?

  6. SIDE EFFECT: • Occurs when a drug acts on a non target organ, producing an undesirable effect • Is dose related reaction • NOT part of the desired therapeutic outcome • Predictable • Dose-related • Acts on nontarget organs • E.G include: stomachache, headache, nausea, vomiting, local effects 6

  7. IDIOSYNCRATIC REACTION: • Genetically related abnormal response • This is a reaction that is neither a side effect nor an allergic reaction. • Some are genetically determined abnormal reactions. • Some are due to an immunologic mechanism. • E.G: Eskimos metabolize certain drugs faster than other populations; therefore, a larger dose of those drugs would be needed in that population 7

  8. DRUG ALLERGY: • Immunologic response to drug • Can be mild as a rash or severe as anaphylaxis • Neither predictable or dose-related • Specific reactions: • Hives • Urticaria (rash, itching) • Inability to breath • Anaphylaxis 8

  9. INTERFERENCE WITH NATURAL DEFENSE MECHANISMS: • The drug reduces body’s ability to fight infection(eg. adrenocorticosteroids); • Drugs that interfere with the body’s defenses can cause more infections 9

  10. 10

  11. EG: Treatment for Allergic Reaction • Mild Reaction – antihistamine • Anaphylactic reaction – epinephrine subcutaneously • True allergy vs. Side effect 11

  12. Remember • When using a drug - The beneficial effect must be weighed against its potential for adverse reactions

  13. Clinical Manifestations of Adverse Reactions • Exaggerated Effect on Target Tissues • An extension of the therapeutic effect caused by: • overreaction of the sensitive patient OR • a dose that is too large for the patient. • In cases of systemic diseases such as kidney or liver disease,the disease may interfere with the metabolism or excretion of the drug therefore, the action of the drug may be enhanced or prolonged. 13

  14. Clinical Manifestations of Adverse Reactions • Effect on Non-target tissues • Caused by a non-therapeutic action of the drug. • Reactions can occur at usual doses but appear more often at higher doses • A reduction in the dose of the drug will usually reverse the adverse reaction. 14

  15. Clinical Manifestations of Adverse Reactions • Effect on Fetal Development (Teratogenic Effect) • TERATOGENIC- comes from the Greek prefix terato-meaning “monster” and the suffix-genic; meaning “producing” a malformed fetus. • There is a relationship between drugs and congenital abnormalities. • eg. thalidomide an OTC drug was found to cause short arms and legs in the exposed fetus. Used as a sedative/hypnotic & also used to treat leprosy. These drugs in dentistry are considered the ‘safest’ : penicillin and erythromycin, acetaminophen (Tylenol), and the local anesthetic lidocaine (Xylocaine). 15

  16. Clinical Manifestations of Adverse Reactions Effect on Fetal Development (Teratogenic Effect) • Early in pregnancy (first trimester) the organs in the fetus are forming, which is considered the most critical time for teratogenicity. • Drugs taken during the 2nd and 3rd trimester stages may affect the newborn, but the fetus is fully developed. • Fetal organogenesis has already occurred, therefore critical stages in fetal development have passed. 16

  17. Clinical Manifestations of Adverse Reactions • LocalEffect • Local tissue irritation • Occasionally, injectable drugs can produce irritation, pain, and tissue necrosis at the site of injection • Topically applied agents can produce irritation at the site of application • Drugs taken orally can produce gastrointestinal symptoms such as nausea 17

  18. Clinical Manifestations of Adverse Reactions • Drug Interaction • A drug interaction can occur when the effect of one drug is altered by another drug • Interactions may result in toxicity or lack of efficacy • Interactions may also produce beneficial effects • The likelihood that a drug interactions would occur increases with the number of drugs a patient is taking 18

  19. Clinical Manifestations of Adverse Reactions • Hypersensitivity (Allergic Reaction) • Occurs when the immune system of an individual responds to the drug administered or applied • Neither dose dependent nor predictable • Intensity increases with subsequent exposures • May be life-threatening 19

  20. Hypersensitivity (Allergic Reaction) • Drug allergy can be divided into 4 types of reactions, depending on the type of antibody produced or the cell mediating the reaction: • Type I: Immediate • Type II: Cytotoxic/Cytolytic • Type III: Immune complex/Arthus/Serum sickness • Type IV: Delayed Hypersensitivity 20

  21. HINT: STUDY ALL THE TYPES OF ALLERGIC REACTIONS Hypersensitivity (Allergic Reaction) TYPE I • Mediated by immunoglobulin E (IgE) antibodies • When a drug antigen binds to IgE antibody, histamine, leukotrienes, and prostaglandins are released, producing vasodilation, edema, and inflammation • Anaphylactic shock or immediate hypersensitivity reactions 21

  22. Hypersensitivity (Allergic Reaction) TYPE I • The targets of this reaction are • Bronchioles, resulting in anaphylactic shock • Respiratory system, resulting in asthma • Skin, resulting in urticaria and dermatitis 22

  23. Hypersensitivity (Allergic Reaction) TYPE I • Because these reactions can occur quickly after drug exposure, they are known as immediate hypersensitivity reactions • Anaphylaxis is an acute, life-threatening allergic reaction characterized by hypotension, bronchospasm, laryngeal edema, and cardiac arrhythmias 23

  24. Hypersensitivity (Allergic Reaction) TYPE II • Complement-dependent reactions involving IgGorIgM antibodies • The antigen-antibody complex is fixed to a circulating red blood cell, resulting in lysis • hypersensitivity causes cytolytic reactions • EG: penicillin-induced hemolytic anemia.

  25. Clinical Manifestations of Adverse Reactions Hypersensitivity (Allergic Reaction) TYPE III • Mediated by IgG • The drug antigen-antibody complex fixes complement and deposits in the vascular endothelium • Manifested as serum sickness; • Includes urticarial skin eruptions, arthralgia (joint pain), arthritis, fever…, with little or no lung involvement • EG: Can be caused by penicillins

  26. Hypersensitivity (Allergic Reaction) TYPE IV • Delayed hypersensitivity reaction • Generally manifested as skin eruptions • Mediated by sensitized T-lymphocytes and macrophages • Examples include allergic contact dermatitis; poison ivy 26

  27. Clinical Manifestations of Adverse Reactions • Idiosyncrasy • Neither a side effect nor an allergic reaction • May be genetically determined • Example: Primaquine-induced hemolytic anemia: Approximately 10% of male African Americans develop a severe hemolytic anemia when given the antimalarial drug primaquine. This is an example of a genetically determined abnormal reaction (idiosyncrasy). 27

  28. Clinical Manifestations of Adverse Reactions • Interference With Natural Defense Mechanisms • A drug’s effect on the body’s defense mechanisms can result in an adverse reaction • Long-term systemic administration of corticosteroids can result in decreased resistance to infection 28

  29. Toxicologic Evaluation of Drugs • LD50 – LETHAL DOSE: • dose of a drug that kills 50% of experimental animals

  30. Toxicologic Evaluation of Drugs • ED50 – MEDIAN EFFECTIVE DOSE: • dose required to produce a specified intensity of effect in 50% of the animals 30

  31. Toxicologic Evaluation of Drugs • Therapeutic Index(TI)- LD50/ED50 >10 needed to produce a therapeutically useful drug • The therapeutic index is the ratio of the LD50 to ED50. The smaller the ratio is, the closer the LD50 is to the ED50 and therefore the closer a deadly dose is to the therapeutic dose. 31

  32. Toxicological Evaluation of Drugs Therapeutic Index Therefore, the lesser the therapeutic index is, the greater the toxicity will be. 32

  33. Toxicologic Evaluation of Drugs CALCULATING THE THERAPEUTIC INDEX (TI)- LD50/ED50 • EXAMPLE: • In an assessment of drug action for a certain therapeutic agent, results indicate that the ED50 is 20 mg/kg, and the LD50 is 400 mg/kg. • What is the therapeutic index for this agent? • One must divide the LD50 value by the ED50 value. The LD50 value (400) divided by the ED50 value (20) equals 20. • THEREFORE, in this example the TI is greater than 10 and is a therapeutically useful drug 33

More Related